4598.T
Delta-Fly Pharma,Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 111.00
−9.02%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- +5.6%
- EPS
- +26.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- +4.0%
Three-year CAGR
- Revenue
- —
- EBITDA
- -21.8%
- EBIT
- -21.7%
- Net income
- -20.4%
- EPS
- +1.6%
- Free cash flow
- -43.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026